This study tests whether adding a special vaccine (dendritic cell vaccine) and an immune-boosting drug (varlilumab) to standard chemotherapy and radiation can help people with newly diagnosed glioblastoma live longer. About 43 participants will receive the vaccine and be randomly…
Phase: PHASE2 • Sponsor: Annick Desjardins, MD • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC